H-alpha-Me-DL-Leu-OH

H-alpha-Me-DL-Leu-OH is a DL (racemic) α-methylated leucine derivative that retains the leucine backbone while introducing an additional stereogenic element at the α-carbon through the H-α-Me substitution pattern. The molecule contains a free carboxylic acid and a secondary amino functionality, enabling standard amino-acid chemistry such as activation for coupling, salt formation, and controlled protection of the amine and acid during synthesis. The α-methyl group increases steric demand and can alter conformational preferences around the peptide bond-forming site, making it a useful chiral or pseudo-chiral building block for peptidomimetic design and stereochemical studies. As an amino acid intermediate, H-alpha-Me-DL-Leu-OH can be incorporated into peptide-like scaffolds or transformed into protected derivatives for downstream synthetic routes where α-substitution and leucine side-chain reactivity are central.

1. Peptide Synthesis

H-alpha-Me-DL-Leu-OH is applied in peptide building and coupling development where α-methylation at the leucine residue can be used to modulate amide bond geometry and local backbone sterics. The free carboxylic acid and amino group support conversion to activated esters or protected amino acid forms, enabling peptide coupling strategies that require temporary N- and C-terminal control. The leucine side chain provides a hydrophobic handle that participates in sequence-dependent folding and can be used to probe how α-substitution affects incorporation efficiency and product distribution in peptide construction. Incorporation of this α-methylated residue can serve as a practical route to peptide analogs and backbone-modified intermediates for synthetic peptide chemistry and method development.

2. Peptidomimetics And SAR

H-alpha-Me-DL-Leu-OH is suitable for peptidomimetic construction in structure-activity relationship studies where α-methyl substitution is used to tune conformational stability and proteolytic susceptibility of peptide-like molecules. The α-methyl group creates steric bias near the amide linkage, while the leucine side chain maintains hydrophobic character that can be leveraged in SAR libraries. The racemic DL nature supports parallel synthesis of mixed stereochemical variants, which can be useful for screening stereochemical effects when paired with separation or stereospecific downstream derivatization. Derivatives prepared from this amino acid, including N-protected forms and side-chain-compatible scaffolds, can be incorporated into analog series used to map stereochemistry-dependent structure-function trends.

3. Chiral Building Block Development

H-alpha-Me-DL-Leu-OH functions as a chiral amino acid intermediate precursor where the α-methylated leucine motif can be carried through protected amino acid synthesis and later resolved or transformed into stereodefined derivatives. The stereogenic α-carbon introduced by the H-α-Me substitution pattern allows downstream stereochemical interrogation through formation of diastereomeric derivatives, salt formation, or conversion to chiral auxiliaries prior to peptide coupling. The free acid and amine enable systematic protection strategies that preserve the α-substitution during synthetic manipulations, including activation for coupling and controlled deprotection for iterative assembly. This makes the compound applicable to chiral synthesis planning for backbone-modified amino acid derivatives and stereochemical studies in amino acid chemistry.

4. Chemical Biology Labeling

H-alpha-Me-DL-Leu-OH can be employed in chemical biology research where α-methylated leucine residues are incorporated into peptide probes or protein-interaction mimics to adjust steric presentation and backbone rigidity. The leucine side chain and amino acid functionality allow conversion into conjugatable building blocks, including N-protected intermediates that can be selectively deprotected for attachment of tags or linkers. The α-methyl group can influence binding-site occupancy and probe stability by altering local conformational preferences around the introduced residue. Downstream derivatization of protected derivatives derived from H-alpha-Me-DL-Leu-OH supports preparation of labeled peptide analogs and biomolecule-modifying reagents used in mechanistic studies and molecular recognition assays.

5. Process Chemistry Intermediate

H-alpha-Me-DL-Leu-OH is relevant to process chemistry and fine chemical synthesis as an amino acid-based intermediate for manufacturing routes to α-methylated leucine derivatives and peptide building blocks. The presence of a free carboxylic acid supports salt formation and controlled activation steps, while the amine can be protected to enable reproducible coupling chemistry under scalable conditions. The sterically hindered α-methyl center can be carried through industrially practical protection, activation, and deprotection sequences that maintain the α-substitution pattern required for downstream peptidomimetic or backbone-modified products. Conversion into protected amino acid derivatives and coupling-ready intermediates derived from H-alpha-Me-DL-Leu-OH can support specialty chemical production and industrial intermediate preparation for peptide and peptidomimetic manufacturing workflows.

1. The spatiotemporal control of signalling and trafficking of the GLP-1R

2. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

3. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

5. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging